A new trading day began on Monday, with Revelation Biosciences Inc (NASDAQ: REVB) stock price up 24.99% from the previous day of trading, before settling in for the closing price of $0.76. REVB’s price has ranged from $0.70 to $25.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -1371.70%. With a float of $4.29 million, this company’s outstanding shares have now reached $4.29 million.
Let’s determine the extent of company efficiency that accounts for 9 employees. In terms of profitability, gross margin is 47.45%, operating margin of -22747.42%, and the pretax margin is -41293.77%.
Revelation Biosciences Inc (REVB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revelation Biosciences Inc is 0.08%, while institutional ownership is 2.31%. The most recent insider transaction that took place on Dec 08 ’23, was worth 14,438. In this transaction Director of this company sold 27,771 shares at a rate of $0.52, taking the stock ownership to the 0 shares.
Revelation Biosciences Inc (REVB) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -35.72 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1371.70% per share during the next fiscal year.
Revelation Biosciences Inc (NASDAQ: REVB) Trading Performance Indicators
Here are Revelation Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.75, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Revelation Biosciences Inc (REVB)
Looking closely at Revelation Biosciences Inc (NASDAQ: REVB), its last 5-days average volume was 2.61 million, which is a jump from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 52.52%. Additionally, its Average True Range was 0.07.
During the past 100 days, Revelation Biosciences Inc’s (REVB) raw stochastic average was set at 8.86%, which indicates a significant decrease from 74.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.39% in the past 14 days, which was lower than the 170.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8291, while its 200-day Moving Average is $1.6855. However, in the short run, Revelation Biosciences Inc’s stock first resistance to watch stands at $1.0239. Second resistance stands at $1.0980. The third major resistance level sits at $1.2199. If the price goes on to break the first support level at $0.8279, it is likely to go to the next support level at $0.7060. Now, if the price goes above the second support level, the third support stands at $0.6319.
Revelation Biosciences Inc (NASDAQ: REVB) Key Stats
With a market capitalization of 4.10 million, the company has a total of 4,293K Shares Outstanding. Currently, annual sales are 0 K while annual income is -120 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,240 K.
